Drugmaker Valeant completes $11 billion purchase of Salix
April 01, 2015 at 09:21 AM EDT
April 1 (Reuters) - Canada's Valeant Pharmaceuticals International Inc completed its $10.96 billion purchase of Salix Pharmaceuticals Ltd, the acquisitive company said on Wednesday.
